Monoclonal antibodies in multiple myeloma: Current and emerging targets and mechanisms of action.

Best Practice & Research. Clinical Haematology
Kitsada WudhikarnAlexander M Lesokhin

Abstract

The recent development of monoclonal antibodies (mAbs) has revolutionized the treatment armamentarium for multiple myeloma. The success of daratumumab and elotuzumab in relapsed/refractory patients, has generated tremendous enthusiasm for mAbs in this disease. Combination treatment with other anti-myeloma treatment modalities and clinical evaluation in newly diagnosed patients are expected to fundamentally change the natural history of the disease. Advances in biopharmaceutical engineering together with a robust interest in novel mAb-derivatives, including antibody drug conjugates and poly-specific antibodies are the next rapidly approaching treatment frontier in multiple myeloma. In this review, we comprehensively outline the currently available evidence and the future landscape of mAbs and mAb-derivative therapies in multiple myeloma.

References

Apr 20, 2014·Frontiers in Immunology·Nelly RobillardMarie C Béné
Mar 3, 2015·Drug Discovery Today·Roland E Kontermann, Ulrich Brinkmann
Jun 3, 2015·The New England Journal of Medicine·Sagar LonialUNKNOWN ELOQUENT-2 Investigators
Aug 27, 2015·The New England Journal of Medicine·Henk M LokhorstPaul G Richardson
Sep 19, 2015·Blood·Aaron P Rapoport
Jul 2, 2016·Journal of Hematology & Oncology·Larysa SanchezMichael L Wang
Aug 25, 2016·The New England Journal of Medicine·Antonio PalumboUNKNOWN CASTOR Investigators
Oct 6, 2016·The New England Journal of Medicine·Meletios A DimopoulosUNKNOWN POLLUX Investigators
Dec 13, 2017·The New England Journal of Medicine·María-Victoria MateosUNKNOWN ALCYONE Trial Investigators
Apr 21, 2018·British Journal of Haematology·Craig T Wallington-BeddoeStuart M Pitson
May 29, 2018·Clinical Lymphoma, Myeloma & Leukemia·Alex F Herrera, Arturo Molina
Nov 8, 2018·The New England Journal of Medicine·Meletios A DimopoulosJesús San-Miguel
Dec 14, 2018·International Journal of Molecular Sciences·Hanley N Abramson
Jan 9, 2019·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Mar 29, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Christina L Zuch de ZafraOlivier Nolan-Stevaux
Mar 31, 2019·Blood Cancer Journal·Thomas MartinJoseph Mikhael
Apr 2, 2019·Clinical Lymphoma, Myeloma & Leukemia·Sundar JagannathKenneth C Anderson
Apr 27, 2019·Clinical Lymphoma, Myeloma & Leukemia·Irene GhobrialSagar Lonial
May 30, 2019·The New England Journal of Medicine·Thierry FaconUNKNOWN MAIA Trial Investigators
Jun 9, 2019·Nature Reviews. Drug Discovery·Aran F LabrijnPaul W H I Parren
Jul 5, 2019·Molecular Cancer Therapeutics·Tatsushi KodamaKoichi Akashi
Sep 11, 2019·Journal of Hematology & Oncology·Bo Yu, Delong Liu

❮ Previous
Next ❯

Citations

Jul 15, 2020·Journal of Clinical Medicine·Xiang ZhouSophia Danhof
Jul 25, 2020·Haematologica·Annamaria Gulla, Kenneth C Anderson
Jan 9, 2021·Expert Opinion on Biological Therapy·Massimo Martino, Annalisa Paviglianiti
Sep 22, 2020·Panminerva Medica·Federico VozellaClaudio Cerchione
Nov 21, 2020·Pharmaceuticals·Massimo Offidani, Maria Teresa Petrucci
Oct 16, 2020·Haematologica·Annamaria Gulla, Kenneth C Anderson
Apr 20, 2021·Drugs·Radowan A Elnair, Sarah A Holstein
Jun 11, 2021·Immunological Reviews·Stephanie Trezise, Stephen L Nutt
Jun 22, 2021·ACS Pharmacology & Translational Science·Rachel L Mynott, Craig T Wallington-Beddoe
Aug 6, 2021·Targeted Oncology·James E Frampton

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

American Society of Clinical Oncology Educational Book
Jacob LaubachJoseph Mikhael
Clinical Advances in Hematology & Oncology : H&O
Pia SondergeldTorben Plesner
© 2021 Meta ULC. All rights reserved